PNC Financial Services Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-221
Closed -$17K 4762
2015
Q3
$17K Buy
221
+45
+26% +$3.36K ﹤0.01% 3467
2015
Q2
$13K Buy
176
+132
+300% +$7.07K ﹤0.01% 3710
2015
Q1
$2K Hold
44
﹤0.01% 4407
2014
Q4
$2K Hold
44
﹤0.01% 3911
2014
Q3
$1K Hold
44
﹤0.01% 3940
2014
Q2
$2K Hold
44
﹤0.01% 3618
2014
Q1
$2K Buy
+44
New +$1.97K ﹤0.01% 3603

PNC Financial Services Group's KYTH Position: Q4 2015 in Review

PNC Financial Services Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 221 shares — an estimated $17K sold.

PNC Financial Services Group first reported a position in KYTH in Q1 2014 and held it in 7 quarters. The position peaked at $17K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • PNC Financial Services Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 221 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $17K.
  • PNC Financial Services Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 7 quarters.
  • PNC Financial Services Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $17K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on PNC Financial Services Group's 13F filing for Q4 2015, filed 5 Feb 2016.